Researchers identify new therapeutic targets on SARS-CoV-2 Spike protein
Researchers have found that the S1/S2 cleavage of the SARS-CoV-2 Spike protein could be a potential target for COVID-19 therapeutics.
List view / Grid view
Researchers have found that the S1/S2 cleavage of the SARS-CoV-2 Spike protein could be a potential target for COVID-19 therapeutics.
Using a mouse model, researchers found that cancer progression led to fewer skeletal muscle ribosomes, likely explaining muscle wasting.
A key modifier has been identified by researchers in a large fruit fly genetic deletion related to neurodevelopmental disorders such as schizophrenia and autism.
Researchers have created an algorithm that locates and analyses DNA structures which are linked to the development of certain diseases.
Researchers have developed a new treatment method which turned glial cells into functioning neurons in mice after stroke.
Computational modelling has been used to design proteins that mimic the conserved protein surface of different strains of HIV for use in vaccines...